Voltaren Emulgel gel for external use

Valsts: Armēnija

Valoda: angļu

Klimata pārmaiņas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktīvā sastāvdaļa:

diclofenac (diclofenac diethylamine)

Pieejams no:

GlaxoSmithKline Consumer Healthcare S.A.

ATĶ kods:

M02AA15

SNN (starptautisko nepatentēto nosaukumu):

diclofenac (diclofenac diethylamine)

Deva:

20mg/g

Zāļu forma:

gel for external use

Vienības iepakojumā:

50g laminated tube, 100g laminated tube

Receptes veids:

OTC

Autorizācija statuss:

Registered

Autorizācija datums:

2020-09-05

Produkta apraksts

GSK Consumer Healthcare S.A.,
Switzerland.
Summary of Product Characteristics
Global Labeling
VOLTAREN EMULGEL
Gel
Diclofenac diethylamine 2.32%
SUMMARY OF PRODUCT CHARACTERISTICS
Document status:
FINAL
Release date:
13 Apr 2020
Number of pages:
8
GSK Consumer Healthcare S.A.,
Switzerland.
Summary of Product Characteristics
TABLE OF CONTENTS
1
NAME OF THE MEDICINAL PRODUCT
.......................................................................
3
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
............................................. 3
3
PHARMACEUTICAL FORM
............................................................................................
3
4
CLINICAL PARTICULARS
..............................................................................................
3
4.1
Pharmacotherapeutic group
.....................................................................................
3
4.2
Posology and method of administration
.................................................................. 3
4.3
Contraindications
.....................................................................................................
4
4.4
Special warnings and precautions for use
................................................................ 4
4.5
Interaction with other medicinal products and other forms of
interaction .............. 5
4.6
Pregnancy and lactation
...........................................................................................
5
4.7
Effects on ability to drive and use machines
........................................................... 5
4.8
Undesirable effects
..................................................................................................
5
4.9
Overdose
..................................................................................................................
6
5 PHARMACOLOGICAL PROPERTIES
..........................................................................
6
5.1 Pharmacodynamic properties
....................................................................................